Octave Bioscience

Octave Bioscience develops the Octave® MSDA Test, the first multi-analyte blood test designed to measure multiple sclerosis disease activity. Their innovative diagnostic tools provide personalized insights to empower patients and providers in managing MS, with nationwide availability through Quest Diagnostics®. The company is also advancing precision medicine for other neurodegenerative diseases.